Saint-Gobain Acquires Irish Pharmaceutical Business
Saint-Gobain's Performance Plastics Life Sciences business in Solon has acquired the pharmaceutical business of Micro Hydraulics Ltd., a Dublin-based supplier and manufacturer of single-use components and systems for the pharmaceutical and biopharmaceutical industries.
Terms were not disclosed.
"The acquisition of the Micro Hydraulics Pharma business is a continuation of our long term strategy to expand our service and product offerings while increasing our localized presence for our customers," said Steve Maddox, general manager of the Saint-Gobain Life Sciences business, in a news release. "We're excited to preserve and build upon the exceptional service model that the Micro team has created, while leveraging our World Class Manufacturing and Quality Systems to bring an enhanced value offering to our customers in the region."
Micro Hydraulics was founded in 1982. In 2005, it created its pharmaceutical division to focus on that emerging industry in Ireland. Today, it is one of the region's "leading providers of single-use fluid handling solutions for high purity applications in pharmaceutical and bioprocessing industries," according to the release. The hydraulic and industrial divisions of the business are not affected by the transaction.
Saint-Gobain Life Science operates out of 19 manufacturing locations across the globe.
2026-09-03
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Saint-Gobain Expands Its Construction Chemicals Operations in Indonesia
-
Saint-Gobain’s Triple Acquisition: The “Small but Sophisticated” Strategy Behind Low-Carbon Building Materials
-
Saint-Gobain Makes Construction Chemicals Acquisitions in Canada, Italy, and Peru
-
Saint-Gobain divests plastic parts business ‘Freeglass’
-
Saint-Gobain to acquire Mexican construction chemicals company Ovniver Group for $815 million
-
P&G launched the first major group acquisition in 2023
-
Rainbow acquires S.A. to accelerate market expansion in the EU
-
China丨Grand Holding acquired Microbe with ¥ 830 million to lay out for biopesticide industry chain
-
China丨Maxunitech acquired Shijie, became the tops in Sulfentrazone, Flumioxazin technical production capacity
-
China丨Flagchem acquired 100% equity of Suke to improve its formulation capacity
Recommend Reading
-
When BASF Lets Agriculture Fly Solo: A Capital Repricing of Scale and Ambition
-
Lier Chemical Gains Momentum as Chlorantraniliprole Supply Stabilizes
-
Novo Nordisk’s Oral Wegovy Wins EU Approval as Weight-Loss Competition Shifts from Injections to Pills
-
AstraZeneca Pays Up to $1.5 Billion for Global Rights to Chinese Lung Cancer Drug
-
Wanhua Chemical and Xingfa Group Jointly Develop 5.32 Billion Yuan Phosphate Mine
-
Premium Global Chemical Sourcing Requests (17 - 22 Jan, 2026)
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
Downstream Demand Insufficient, Cyclohexane Market Negotiation Focus Shifts Lower
-
Insufficient cost support + weak demand: Melamine continues its weak consolidation
-
Polyethylene prices reduced, short-term weak operation